Immunorecovered but Exhausted: Persistent PD-1/PD-L1 Expression Despite Virologic Suppression and CD4 Recovery in PLWH

<b>Background/Objectives:</b> While ART effectively suppresses HIV viremia, many PLWH exhibit persistent immune dysfunction. This study aimed to assess immune recovery and immune exhaustion (PD-1/PD-L1 expression) in newly diagnosed versus long-term ART-treated individuals. <b>Methods:</b> We analyzed 79 PLWH: 52 newly diagnosed individuals (12-month follow-up) and 27 long-term-treated patients (Ukrainian refugees). Flow cytometry was used to evaluate CD4+ and CD8+ counts, the CD4+/CD8+ ratio, and PD-1/PD-L1 expression on CD3+, CD4+, and CD19+ lymphocytes. ART regimen and HIV subtype were included as covariates in linear regression models. <b>Results:</b> At 12 months, CD4+ counts were similar between groups (median 596.5 vs. 621 cells/μL, <i>p</i> = 0.22), but newly diagnosed patients had higher CD8+ counts (872 vs. 620 cells/μL, <i>p</i> = 0.028) and a lower CD4+/CD8+ ratio (0.57 vs. 1.05, <i>p</i> = 0.0027). Immune exhaustion markers were significantly elevated in newly diagnosed individuals: CD4+ PD-1+ T cells (24.4% vs. 3.85%, <i>p</i> = 0.0002) and CD3+ PD-1+ T cells (27.3% vs. 12.35%, <i>p</i> < 0.0001). Linear regression confirmed group membership independently predicted higher CD3+ (β = +21.92, <i>p</i> < 0.001), CD4+ (β = +28.87, <i>p</i> < 0.0001), and CD19+ (β = +8.73, <i>p</i> = 0.002) percentages. Lipid parameters and SCORE2 did not differ significantly. <b>Conclusions:</b> Despite virologic suppression and CD4+ recovery, immune exhaustion markers remain elevated in newly diagnosed PLWH, suggesting incomplete immune normalization. Traditional parameters (CD4+ count and CD4+/CD8+ ratio) may not fully capture immune status, warranting broader immunologic profiling in HIV care.